A Phase I Trial of MK-0731, a Kinesin Spindle Protein (KSP) Inhibitor, in Patients With Solid Tumors

Investigational New Drugs - Netherlands
doi 10.1007/s10637-011-9653-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2008English

Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2009English

A Phase I Trial of UCN-01 and Prednisone in Patients With Refractory Solid Tumors and Lymphomas

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients With Refractory, Locally Advanced or Metastatic Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2011English

O3-2-5a Phase I Trial of BI 754091, a Programmed Death Receptor 1 (PD-1) Inhibitor, in Patients With Advanced Solid Tumors

Annals of Oncology
MedicineOncologyHematology
2018English

A Phase I Study of BI 811283, an Aurora B Kinase Inhibitor, in Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies

Clinical Cancer Research
Cancer ResearchOncology
2015English

First‐in‐human Phase I Study of E7090, a Novel Selective FGFR Inhibitor, in Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2020English

Phase I Dose Escalation Study of Sodium Stibogluconate (SSG), a Protein Tyrosine Phosphatase Inhibitor, Combined With Interferon Alpha for Patients With Solid Tumors

Journal of Cancer
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy